Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase [Genetics]

Inactivation of the retinoblastoma gene (RB1) product, pRB, is common in many human cancers. Targeting downstream effectors of pRB that are central to tumorigenesis is a promising strategy to block the growth of tumors harboring loss-of-function RB1 mutations. One such effector is retinoblastoma-binding protein 2 (RBP2, also called JARID1A or...

from Genetics via xlomafota13 on Inoreader https://ift.tt/2HJuTV6
via IFTTT